Cold atmospheric pressure plasma: A potential physical therapy for rheumatoid arthritis hyperplastic synovium.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 20 06 2023
revised: 13 07 2023
accepted: 27 07 2023
medline: 22 9 2023
pubmed: 3 8 2023
entrez: 2 8 2023
Statut: ppublish

Résumé

The most significant pathological change in rheumatoid arthritis (RA) is synovial hyperplasia within the joint. The production of a series of degrading enzymes and oxidative stress caused by synovial hyperplasia lead to severe bone and cartilage damage in rheumatoid joints. The core effector cell in hyperplastic synovium is fibroblast-like synovium cells, which can invade cartilage, cause inflammation, destroy joints, and show tumor-like anti-apoptosis characteristics. This study focused on the effect of cold atmospheric pressure plasma on proliferative synovium, and the results showed that no synovial hyperplasia, angiogenesis, or inflammatory infiltration was observed after cold atmospheric pressure plasma (CAP) treatment. The molecular and cellular mechanisms also reveal the spontaneous reactive oxygen species (ROS) cascade inducing apoptosis in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) cells. This study proposes a potential physical therapy method for treating proliferative synovium and also provides ideas for the application of CAP in other types of tumor diseases.

Identifiants

pubmed: 37531824
pii: S1567-5769(23)01057-3
doi: 10.1016/j.intimp.2023.110732
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110732

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Chengbiao Ding (C)

School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China; Department of Rehabilitation Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, China; Research Center for Translational Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, China.

Qi Liu (Q)

School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.

Wenchong Ouyang (W)

School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.

Yichen Sun (Y)

The Division of Life Sciences and Medicine of the University of Science and Technology of China, China.

Quan Liu (Q)

School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.

Shuzhan Gao (S)

School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.

Zhengwei Wu (Z)

School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China; Institute of Advanced Technology, University of Science and Technology of China, Hefei 230000, China. Electronic address: wuzw@ustc.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH